Such an immune “afferent” and “efferent” system, although inefficient, also provides the prerequisite for the activation of the antitumor immune response, and thus the infiltration of CD8 T cells is associated with improved prognosis in patients with newly diagnosed GBM (Yang et al., 2010). Here, CD8A is linked to glioblastoma.